Related Experiment Video
Updated: Feb 15, 2026

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
Published on: February 28, 2021
White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk
Per E Lønning1, Elisabet O Berge1, Merete Bjørnslett2
1University of Bergen and Haukeland University Hospital, Bergen, Norway (P.E.L., E.O.B., L.M., R.C., S.B., C.E., L.B., H.B.S., S.K.).
Normal tissue BRCA1 promoter methylation is linked to increased ovarian cancer risk, particularly high-grade serous ovarian cancer (HGSOC). This finding suggests a potential biomarker for HGSOC development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The role of normal tissue gene promoter methylation in cancer risk is not well understood.
- BRCA1 promoter methylation in normal tissue may influence cancer development.
Purpose of the Study:
- To investigate the association between normal tissue BRCA1 promoter methylation and ovarian cancer risk.
- To determine if BRCA1 methylation is a risk factor for specific subtypes of ovarian cancer, such as high-grade serous ovarian cancer (HGSOC).
Main Methods:
- Two case-control studies were conducted with a total of 1541 patients and 3682 control participants.
- White blood cell (WBC) BRCA1 promoter methylation was analyzed using methylation-specific quantitative polymerase chain reaction.
- Methylation prevalence was compared between ovarian cancer patients and controls, including HGSOC and other subtypes.
Main Results:
- BRCA1 methylation was more frequent in ovarian cancer patients than controls (6.4% vs. 4.2%).
- Elevated BRCA1 methylation was specifically associated with HGSOC (9.6% in patients vs. 4.3% in controls, OR=2.22).
- Nonserous and low-grade serous ovarian cancer subtypes did not show a significant association with BRCA1 methylation.
Conclusions:
- Constitutively normal tissue BRCA1 promoter methylation is positively associated with the risk of developing HGSOC.
- BRCA1 methylation in normal tissue may serve as a potential biomarker for HGSOC risk.
More Related Videos
14:25Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
Related Concept Videos
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Relative Risk
Marcia's Theory of Identity Status
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Ovarian Cycle